EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $334,000 | -60.3% | 4,813 | -69.5% | 0.00% | – |
| Q4 2017 | $842,000 | -59.9% | 15,767 | -55.3% | 0.00% | – |
| Q3 2017 | $2,102,000 | -24.4% | 35,245 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $2,780,000 | +584.7% | 35,245 | +619.7% | 0.00% | – |
| Q1 2017 | $406,000 | -46.4% | 4,897 | -73.8% | 0.00% | – |
| Q1 2016 | $757,000 | -72.1% | 18,700 | -38.9% | 0.00% | -100.0% |
| Q4 2015 | $2,715,000 | +39.7% | 30,617 | +16.6% | 0.00% | 0.0% |
| Q3 2015 | $1,943,000 | +352.9% | 26,250 | +395.3% | 0.00% | – |
| Q2 2015 | $429,000 | – | 5,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |